[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:gliosarcoma":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":123,"states":128},"Gliosarcoma",18,14,[8,16,22,28,35,41,47,53,60,66,72,78,84,90,96,103,110,117],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT07089641","ERAS-801 for the Treatment of Resectable and Progressive or Recurrent or Elderly Newly Diagnosed IDH Wildtype Grade IV Glioblastoma or Gliosarcoma With an EGFR Amplification or Mutation, ERAS801-SARG Trial",[12],"Phase 1","RECRUITING","2026-08-26T02:19:19.975067Z","2026-07-24T01:27:14.899532Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":20,"content_modified":21},"NCT07343986","Study of Low-Intensity Focused Ultrasound in Combination With Immunotherapy in Newly Diagnosed Unmethylated Glioblastoma",[12],"2026-08-26T02:17:47.813245Z","2026-05-05T02:43:28.826957Z",{"nct_id":23,"title":24,"phases":25,"status":13,"updated_at":26,"content_modified":27},"NCT06934889","Study of ABBV-637 or ABBV-155 With ERAS-801 for People With Glioblastoma",[12],"2026-08-26T02:15:11.740957Z","2026-05-05T02:43:28.728093Z",{"nct_id":29,"title":30,"phases":31,"status":13,"updated_at":33,"content_modified":34},"NCT05465954","Efineptakin Alfa and Pembrolizumab for the Treatment of Recurrent Glioblastoma",[32],"Phase 2","2026-08-26T02:19:29.922117Z","2026-05-05T02:43:28.414873Z",{"nct_id":36,"title":37,"phases":38,"status":13,"updated_at":39,"content_modified":40},"NCT05052957","hSTAR GBM (Hematopoetic Stem Cell (HPC) Rescue for GBM)",[32],"2026-08-26T02:17:30.961790Z","2026-05-05T02:43:27.959629Z",{"nct_id":42,"title":43,"phases":44,"status":13,"updated_at":45,"content_modified":46},"NCT06344130","Hypofractionation Trial of Re-irradiation in Good Prognosis Recurrent Glioblastoma",[12],"2026-08-26T02:18:27.904411Z","2026-05-05T02:43:26.664688Z",{"nct_id":48,"title":49,"phases":50,"status":13,"updated_at":51,"content_modified":52},"NCT07579208","A Phase1 Clinical Trial Evaluating Locoregional Delivery Of Engineered NK Cells Containing IL13Ra And EGFvIII Chimeric Antigen Receptor (CAR), IL-21 Secretion And Deleted TGF-BetaR2 And NR3C1 In Recurrent Glioblastoma",[12],"2026-08-26T02:15:28.524219Z","2026-05-13T02:55:06.783715Z",{"nct_id":54,"title":55,"phases":56,"status":13,"updated_at":58,"content_modified":59},"NCT05084430","Study of Pembrolizumab and M032 (NSC 733972)",[57],"Phase 1\u002FPhase 2","2026-08-26T02:19:10.436356Z","2026-05-05T02:43:28.856519Z",{"nct_id":61,"title":62,"phases":63,"status":13,"updated_at":64,"content_modified":65},"NCT04991870","Phase I CB-NK-TGF-ßR2-\u002FNR3C1- in rGBM",[12],"2026-08-26T02:17:38.215063Z","2026-05-05T02:43:27.836164Z",{"nct_id":67,"title":68,"phases":69,"status":13,"updated_at":70,"content_modified":71},"NCT03896568","MSC-DNX-2401 in Treating Patients With Recurrent High-Grade Glioma",[12],"2026-08-26T02:18:19.586423Z","2026-05-05T02:35:31.905843Z",{"nct_id":73,"title":74,"phases":75,"status":13,"updated_at":76,"content_modified":77},"NCT04541082","Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms",[12],"2026-08-26T02:18:37.277498Z","2026-05-05T02:43:29.163334Z",{"nct_id":79,"title":80,"phases":81,"status":13,"updated_at":82,"content_modified":83},"NCT05857969","Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling",[12],"2026-08-26T02:18:00.873391Z","2026-05-05T02:43:28.220097Z",{"nct_id":85,"title":86,"phases":87,"status":13,"updated_at":88,"content_modified":89},"NCT05698524","A Study of Temodar With Abexinostat (PCI-24781) for Patients With Recurrent Glioma",[12],"2026-08-26T02:17:20.511551Z","2026-05-05T02:35:31.632941Z",{"nct_id":91,"title":92,"phases":93,"status":13,"updated_at":94,"content_modified":95},"NCT05756985","Improving Understanding of Glioblastoma Through Preservation of Biologically Active Brain Tissue",[],"2026-08-26T02:15:13.282904Z","2026-05-13T02:55:06.375162Z",{"nct_id":97,"title":98,"phases":99,"status":100,"updated_at":101,"content_modified":102},"NCT06896110","Intrathecal Azacitidine and Nivolumab in Patients With Recurrent High-grade Glioma",[12],"ENROLLING_BY_INVITATION","2026-08-26T02:15:00.557154Z","2026-06-16T05:54:07.840721Z",{"nct_id":104,"title":105,"phases":106,"status":107,"updated_at":108,"content_modified":109},"NCT05039281","Atezolizumab and Cabozantinib for the Treatment of Recurrent Glioblastoma",[57],"ACTIVE_NOT_RECRUITING","2026-08-03T03:26:30.254593Z","2026-05-05T02:43:28.706164Z",{"nct_id":111,"title":112,"phases":113,"status":114,"updated_at":115,"content_modified":116},"NCT05363826","Intracavitary Photodynamic Therapy as an Adjuvant to Resection of Glioblastoma or Gliosarcoma Using IV Photobac®",[12],"UNKNOWN","2026-08-03T03:16:06.901903Z","2026-05-05T02:43:28.315267Z",{"nct_id":118,"title":119,"phases":120,"status":107,"updated_at":121,"content_modified":122},"NCT04555577","Peposertib and Radiation Therapy, Followed by Temozolomide for the Treatment of Patients With Newly Diagnosed MGMT Unmethylated Glioblastoma or Gliosarcoma",[12],"2026-08-03T02:34:16.012157Z","2026-05-05T02:43:28.214119Z",[124],{"biomarker":125,"count":126,"slug":127},"IDH1 wt Allele",3,"idh1-wt-allele",[129,133,136],{"state":130,"count":131,"slug":132},"Texas",5,"texas",{"state":134,"count":126,"slug":135},"Florida","florida",{"state":137,"count":126,"slug":138},"New York","new-york"]